Abacavir

Abacavir is an antiretroviral medication, specifically a nucleoside reverse transcriptase inhibitor (NRTI). It is used in the treatment of HIV, a virus that attacks the immune system, leaving the body susceptible to infections and diseases. By inhibiting the reverse transcriptase enzyme, abacavir prevents the virus from replicating and spreading within the body.
Abacavir is often prescribed as part of a combination therapy, alongside other antiretroviral drugs, to provide comprehensive and effective treatment. Combination therapy is essential for managing HIV, as it targets the virus at multiple points in its life cycle, making it more difficult for the virus to develop resistance.
Abacavir is available in various forms, including tablets and oral solution, allowing for flexible dosing options to meet individual patient needs. The medication is typically prescribed as a once-daily regimen, but the dosage and duration may vary depending on the patient’s specific needs and treatment plan.
Patients with a history of hypersensitivity reactions to abacavir should avoid using the medication, as it may cause severe and potentially life-threatening side effects. Healthcare providers should closely monitor patients for any signs of abacavir hypersensitivity during treatment.